Alternatives to Coralert

Vectorious Medical Technologies developed the V-LAP, the world's first in-heart microcomputer for optimal heart disease treatment.

Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.

TytoCare provides a Home Smart Clinic solution enabling accessible, high-quality primary care from home through remote physical exams.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

MedHub-AI develops an AI-based decision support system for interventional cardiologists to enable precision cardiac care.

Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.

AI-powered diagnostic platform detecting and interpreting inaccessible body infra-sounds for enhanced medical diagnosis.

Developing no-contact guided ablation technology for atrial fibrillation treatment.

Pioneering transcatheter technology for tricuspid regurgitation with a novel cross-caval approach.

Developing autonomous robotic phlebotomy devices to standardize blood collection and improve patient care.

CardiacSense develops a CE and FDA-cleared medical watch for continuous cardiac monitoring and arrhythmia detection.

Developing advanced diagnostic technology to expand global access to healthcare.

Mon4t develops smartphone-based medical tests for neurological disorders, providing real-time monitoring and feedback to patients and physicians.

Augmedics uses augmented reality to provide surgeons with 'x-ray vision' for spine procedures.

Global healthcare company using focused ultrasound guided by MRI for therapeutic treatments.

Digital physical therapy and recovery platform using everyday sensors for ongoing health diagnostics.

Medical technology company optimizing coronary artery disease therapy decisions with FFR-based assessment.

Developing the first robotic surgery platform for cataracts and widespread eye diseases.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.